- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04540562
Evaluating a Mobile Self-management Application for Patients With COPD Chronic Obstructive Pulmonary Disease
August 31, 2020 updated by: Rijnstate Hospital
Evaluating the Feasibility of a Mobile Self-management Application for Patients With Chronic Obstructive Pulmonary Disease (COPD)
The objective of the study is to evaluate the effects of a mobile self-management app in clinical practice for recently discharged COPD patients on application use, self-management, anxiety and depression, expectations and experiences, patients' and health care professionals' satisfaction and hospital readmissions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Usability testing techniques were used to receive feedback on a prototype of the app, before starting the feasibility study.
Patients were recruited from a large teaching hospital.
The COPD app provided patients with an 8 week self-management program.
The application had three views: timeline, information page, and contact page.
The start date was each patients' date of discharge.
The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires.
The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app.
The timeline consisted of the lung exacerbation action plan, medication overview, weekly questionnaires and monitoring, and consultations (video consultation after 4 weeks and face-to-face consultation after 8 weeks).
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arnhem, Netherlands, 6815AD
- Rijnstate
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 18 Years
- Diagnosed with COPD
- Admissions to the hospital for exacerbation
- Having (access to) a tablet or smartphone
- Working internet connection
- Proficiency in using a tablet or smartphone
- Ability to read and understand the Dutch language
- Signed informed consent
- At least one hospitalization for COPD exacerbation in the year preceding the study (outcome was...)
Exclusion Criteria:
- No exacerbation of COPD
- Comorbidities: cancer, severe cognitive or psychiatric comorbidities
- No access to a tablet or smartpone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention
The COPD app consisted of an 8 week self-management program.
The app had three views: timeline, information page, and contact page.
The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires.
The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app.
A video consultation was planned after after 4 weeks and a face-to-face consultation after 8 weeks.
|
The COPD app consisted of an 8 week self-management program.
The app had three views: timeline, information page, and contact page.
The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires.
The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app.
A video consultation was planned after after 4 weeks and a face-to-face consultation after 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use (feasibility)
Time Frame: Week 1 through week 20
|
Use based on log data: number of times the app was used per week.
|
Week 1 through week 20
|
|
Satisfaction (feasibility)
Time Frame: Week 8
|
Questionnaires were used to assess satisfaction, information and user-friendliness of the app.
The items were rated on a 7 point scale, varying from 1 (totally disagree) to 7 (totally agree).
Overall satisfaction was rated on a scale from 1 (very unsatisfied) to 10 (very satisfied).
Multiple response questions were used to assess if patients missed information in the app.
Suggestions for improvement were asked using an open question.
Yes/no questions were used to assess satisfaction with video consultation(s) (additional requested video consultations, problems and time saving).
|
Week 8
|
|
Overall satisfaction (feasibility)
Time Frame: Week 20
|
Overall satisfaction was rated on a scale varying from 1 (not satisfied) to 10 (very satisfied).
Suggestion for improvement were assessed with an open question.
|
Week 20
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-management - change over time
Time Frame: Baseline, week 8 and week 20
|
Self-management using Partner in Health Scale.
The items are rated on a 9-point Likert scale varying from 0 (low self-management) to 8 (high self-management).
|
Baseline, week 8 and week 20
|
|
Expectations
Time Frame: Baseline
|
Expectations with technology: using questions covering constructs of Unified Theory of Acceptance and Use of Technology.
The items were rated on a 7 point scale varying from 1 (totally disagree) to 7 (totally agree).
|
Baseline
|
|
Experiences with technology
Time Frame: Week 8
|
Experiences with technology: using questions covering constructs of Unified Theory of Acceptance and Use of Technology.
The items were rated on a 7 point scale varying from 1 (totally disagree) to 7 (totally agree).
|
Week 8
|
|
Experiences with technology
Time Frame: Week 20
|
Experiences with technology: using questions covering constructs of Unified Theory of Acceptance and Use of Technology.
The items were rated on a 7 point scale varying from 1 (totally disagree) to 7 (totally agree).
|
Week 20
|
|
Anxiety - change over time
Time Frame: Week 1 until week 8
|
Hospital Anxiety and Depression Scale.
Seven items were rated on a 4 points Likert scale, varying from 0 (lowest anxiety level) to 3 (highest anxiety level).
|
Week 1 until week 8
|
|
Depression - change over time
Time Frame: Week 1 and Week 8
|
Hospital Anxiety and Depression Scale.
Seven items were rated on a 4 points Likert scale, varying from 0 (lowest depression level) to 3 (highest depression level).
|
Week 1 and Week 8
|
|
Satisfaction nurses
Time Frame: After intervention completion, up to 15 months.
|
Questions to assess nurses' experiences with the application, satisfaction, time investment and integration in their work process.
The items were rated on a 5 point scale, varying from 1 (totally disagree) to 5 (totally agree).
Overall satisfaction was rated on a scale from 1 (not satisfied) to 10 (very satisfied).
|
After intervention completion, up to 15 months.
|
|
Hospital readmissions
Time Frame: 30 days
|
Hospital admissions for at least 24 hours.
The number of hospital admissions was obtained from the Electronic Medical Record.
This was compared with the readmission rate from the previous year, November 2017 until November 2018.
|
30 days
|
|
Hospital readmissions
Time Frame: 8 weeks
|
Hospital admissions for at least 24 hours.
The number of hospital admissions was obtained from the Electronic Medical Record.
This was compared with the readmission rate from the previous year, November 2017 until November 2018.
|
8 weeks
|
|
Hospital readmissions
Time Frame: 20 weeks
|
Hospital admissions for at least 24 hours.
The number of hospital admissions was obtained from the Electronic Medical Record.
This was compared with the readmission rate from the previous year, November 2017 until November 2018.
|
20 weeks
|
|
Use
Time Frame: Week 8
|
Questions about use of the application: number of times and time in minutes (multiple choice question), use of the different functionalities and which functionality is most important (multiple response question), if patients experienced problems (yes/no), received help using the application (yes/no) and if people in their environment helped them using the app (yes/no).
|
Week 8
|
|
Use
Time Frame: Week 20
|
Questions about use of the application: number of times and time in minutes (multiple choice question), use of the different information items and which item is most important (multiple response question), if patients experienced problems (yes/no), received help using the application (yes/no) and if people in their environment helped them using the app (yes/no).
|
Week 20
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age
Time Frame: Baseline
|
Age extracted from Electronic Medical Record.
|
Baseline
|
|
Education
Time Frame: Baseline
|
Multiple choice question.
|
Baseline
|
|
Partner
Time Frame: Baseline
|
Living together with a partner (yes/no question).
|
Baseline
|
|
Children
Time Frame: Baseline
|
Having children (yes/no question).
|
Baseline
|
|
Internet use (duration)
Time Frame: Baseline
|
Multiple choice question, varying from less than six months to more than 3 years
|
Baseline
|
|
Frequency internet use
Time Frame: Baseline
|
Multiple choice question, varying from every day to never.
|
Baseline
|
|
Tablet/smartphone skills
Time Frame: Baseline
|
Question with 5 point scale varying from 1 (very bad) to 5 (very good).
|
Baseline
|
|
Help needed to use app on smartphone/tablet
Time Frame: Baseline
|
Yes/no question.
If yes: open question to answer who was asked for help.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wim van Harten, MD, PhD, Rijnstate Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 22, 2018
Primary Completion (ACTUAL)
April 15, 2019
Study Completion (ACTUAL)
April 25, 2020
Study Registration Dates
First Submitted
August 25, 2020
First Submitted That Met QC Criteria
August 31, 2020
First Posted (ACTUAL)
September 7, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 7, 2020
Last Update Submitted That Met QC Criteria
August 31, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-1257
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on COPD app
-
Boston Scientific CorporationPneumRx, Inc.TerminatedCOPD Symptoms After Coil ProcedureSwitzerland
-
China-Japan Friendship HospitalRecruitingChronic Obstructive Pulmonary DiseaseChina
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; National Institute for Health Research: CLAHRC YH; The... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
NHS Greater Glasgow and ClydeUniversity of GlasgowUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Gelb, Arthur F., M.D.RecruitingEmphysema | COPD, Emphysema, Asthma COPD OverlapUnited States
-
AstraZenecaCompleted
-
Karolinska InstitutetDalarna County Council, SwedenCompleted